Regardless of the antihyperglycemic effects of this drug, there is another advantage, such as preventing the risk of hypoglycemia and weight gain, decreasing the risk of macrovascular complications (sudden death, stroke, acute coronary syndrome, and peripheral vascular disease), improving insulin resistance and lipid profiles, and having a low cost [45-47]. This evidence concerns the gene INS and Hypoglycemia.